In this work, we showed that the CRL1505 strain is capable of increasing the resistance to the secondary pneumococcal pneumonia produced after TLR3 activation or RSV infection through modulation of the gut–lung axis. This evidence concerns the gene TLR3 and pneumococcal pneumonia.